2024年上半年CRRT设备市场洞察报告

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The CRRT (Continuous Renal Replacement Therapy) equipment market accounted for approximately 19.30% of the overall blood purification market by sales in the first half of 2024, with leading brands being Baxter, Fresenius, Jianfan, Shanhai, and B.Braun [9][32] - There is a notable increase in demand for CRRT equipment from county-level hospitals, while procurement from non-county hospitals has decreased [21][32] - The report highlights a significant policy initiative aimed at enhancing critical care services, which is expected to drive demand for CRRT equipment [31] Overall Market Situation - In the first half of 2024, the market share of CRRT equipment in different regions showed a decline in the eastern and northeastern regions, while the western and central regions saw an increase in procurement [13][32] - The top three brands in the eastern region were Fresenius, Baxter, and B.Braun, while in the central region, they were Shanhai, B.Braun, and Jianfan [13][32] - The market share of CRRT equipment in tertiary hospitals decreased, while it increased in secondary hospitals and other procurement units [16][32] Regional Market - The report indicates that the eastern region is dominated by international brands, while local brands like Shanhai and Jianfan are gaining traction in the central and western regions [32] - The procurement share of county-level hospitals for CRRT equipment has significantly increased, with Shanhai, Jianfan, and Fresenius being the top brands [21][32] Product Models - In the first half of 2024, Baxter's Prismaflex had the highest market share at 22.97%, followed by Jianfan's DX-10 at 20.48% [26][27] - The report notes that the average price of Prismaflex is 315,400 CNY, while DX-10 is priced at 251,300 CNY [27] Summary - The report emphasizes that the demand for CRRT equipment is expected to grow due to government policies aimed at improving critical care services and the increasing procurement from county-level hospitals [31][32] - The competitive landscape is shifting, with local brands poised to capture more market share as healthcare policies evolve [32]